StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research report released on Tuesday morning. The brokerage issued a hold rating on the stock.
China Pharma Stock Performance
Shares of CPHI stock opened at $0.18 on Tuesday. The stock has a fifty day simple moving average of $0.22 and a two-hundred day simple moving average of $0.29. China Pharma has a 52-week low of $0.17 and a 52-week high of $1.21. The company has a current ratio of 0.84, a quick ratio of 0.24 and a debt-to-equity ratio of 0.19.
China Pharma (NYSE:CPHI – Get Free Report) last announced its quarterly earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share (EPS) for the quarter. The company had revenue of $0.93 million during the quarter. China Pharma had a negative net margin of 70.47% and a negative return on equity of 60.19%.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Stories
- Five stocks we like better than China Pharma
- Most active stocks: Dollar volume vs share volume
- Does GTA VI Make Take-Two Interactive Stock an Irresistible Buy?
- How to Calculate Options Profits
- Why HPE’s Dip Is a Prime Opportunity for Blue-Chip AI Investors
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Why Analysts See Big Upside for Occidental Petroleum Despite Lows
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
